Details of issuance or disposal
Issuance of Stock Acquisition Rights for Subscription (Paid Stock Options) (株式会社イントランス Series 12 Stock Acquisition Rights)
18,500 Stock Acquisition Rights, 100 shares per right, underlying shares: 1,850,000 shares
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
¥925,000
3.97% (based on 46,552,784 issued shares, assuming all rights are allocated and exercised)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of Stock Acquisition Rights for Subscription (Paid Stock Options) (株式会社イントランス Series 12 Stock Acquisition Rights) |
| Number of shares to be issued or disposed of | 18,500 Stock Acquisition Rights, 100 shares per right, underlying shares: 1,850,000 shares |
| Issue price and disposal price | ¥50 per Stock Acquisition Right |
| Total issue value | ¥925,000 |
| Amount of funds to be raised | Total proceeds of ¥178,525,000 (¥925,000 from the issuance of the Stock Acquisition Rights and ¥177,600,000 from their exercise) |
| Specific use of funds | Details Working capital (funds to maintain liquidity on hand) / Amount ¥178 million / Scheduled timing of expenditures July 2026 to June 2029 |
| Payment date | 9 July 2026 |
| Intended allottee | Name 3 directors of the Company / Number of Shares 10,200 Stock Acquisition Rights (1,020,000 shares), Name 6 employees of the Company / Number of Shares 8,300 Stock Acquisition Rights (830,000 shares) |
| Intended allottee's holding policy | The recipients intend to sell the Company's common shares acquired through exercise in the market and repeatedly exercise the rights using the sale proceeds. The Stock Acquisition Rights cannot be voluntarily renounced. |
| Dilution Rate | 3.97% (based on 46,552,784 issued shares, assuming all rights are allocated and exercised) |
| Total number of issued shares | 46,552,784 shares → 48,402,784 shares(3.97%) |
| Basis for determining the amount to be paid | The exercise price is ¥96 per share, equal to 106% of the closing price of ¥90 on the day before the resolution date, 22 June 2026. This exceeds the one-month, three-month and six-month average closing prices of ¥76.67, ¥69.63 and ¥68.00, respectively. The payment amount of ¥50 per Stock Acquisition Right also exceeds the valuation calculated by an independent valuation agency using a Monte Carlo simulation. |
| Exercise price | Initially ¥96 per share. Adjustment provisions apply for share splits and consolidations, issuances below market value and other events, as well as adjustments within a reasonable range where deemed necessary by the Company. Floor: Not disclosed. |
| Exercise period | From 10 July 2026 to 9 July 2029 (or the preceding bank business day if the final day is not a bank business day) |
| Number of Stock Acquisition Rights | Total issued: 18,500 Stock Acquisition Rights. Unexercised balance: Not disclosed. |
| Reason for acquisition without consideration | If a prescribed event relating to a corporate reorganization or other event occurs, or if a holder of the Stock Acquisition Rights ceases to satisfy the exercise conditions. |
| Categories and Number of Persons Covered | 3 directors of the Company, 10,200 rights (1,020,000 shares), and 6 employees of the Company, 8,300 rights (830,000 shares). The breakdown is 3,700 rights for the Representative Director and President, 4,500 rights for a director, 2,000 rights for a director, and 8,300 rights for 6 employees. |
| Total Stock-Based Compensation | The rights are issued for consideration based on individual investment decisions, rather than as compensation. Total share-based compensation: Not applicable. |
| Procedures under the Corporate Code of Conduct | The Company obtained a valuation from the independent valuation agency 茄子評価株式会社. As the terms are not particularly favorable, shareholder approval was not obtained, and the directors to whom the rights are allocated did not participate in deliberations or resolutions concerning the proposal to issue rights to themselves. |
| Most recent equity financing | Timing 23 June 2026 / Type Series 3 Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights / Amount Not disclosed, Timing 23 June 2026 / Type 11th Series Stock Acquisition Rights / Amount Not disclosed |
| Impact on Business Performance | The impact of the issuance of these Stock Acquisition Rights on performance is Not disclosed. The proceeds are scheduled to be allocated to working capital. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To raise the motivation and morale of directors and employees and strengthen their unity with a view to expanding performance and increasing corporate value over the medium to long term. The rights are also intended to provide an incentive for the share price to rise by making the recipients bear a certain degree of responsibility if the share price declines and share the risk of share price fluctuations with existing shareholders.